Reference
1. Leo S D, Lee S Y and Braverman L E, Hyperthyroidism, Lancet, vol.
388, no. 10047, pp. 906–918, 2016
2. Biondi B, Heart failure and thyroid dysfunction, European Journal of
Endocrinology (2012) 167 609–618 2012
3. MALIK R, and HODGSON H, The relationship between the thyroid gland
and the liver Q J Med 2002; 95:559–569
4. Brent G. The molecular basis of thyroid hormone action. N Engl J Med.
1994;331:847– 853.
5. Danzi S, Klein I. Thyroid
hormone and the cardiovascular system. Minerva Endocrinologica.
2004;29:139 –150
6. Resnick LM, Laragh JH. Plasma
renin activity in syndromes of thyroid hormone excess and
deficiency. Life Sci 1982; 30: 585-6.
7. Biondi B, Palmieri E A, Lombardi G, et al, Effects of thyroid hormone
on cardiac function: the relative importance of heart rate, loading
conditions, and myocardial contractility in the regulation of cardiac
performance in human hyperthyroidism. J Clin Endocrinol Metab 2002,
8. Brandt F, Green A, Hegedüs L, et al A critical review and
meta-analysis of the association between overt hyperthyroidism and
mortality. Eur J Endocrinol 2011; 165: 491-7.
9.Klein I, Ojamaa K. Thyrotoxicosis and the heart. Endocrinol Metab Clin
North Am 1998;27:51-62.
10.Klein I, Danzi S: Thyroid disease and the heart. Circulation 2007,
116:1725. ttp://dx.doi.org/10.1161/CIRCULATIONAHA.106.678326.
11. Petersen P, Hansen JM. Stroke in thyrotoxicosis with atrial
fibrillation. Stroke 1988; 19: 15-8.
12. Akamizu T, Satoh T, Isozaki O, et al. (2012) Diagnostic criteria,
clinical features, and incidence of thyroid storm based on nationwide
surveys. Thyroid 22: 661-679.
13. Satoh T, Isozaki O, Suzuki A, et al 2016 Guidelines for the
management of thyroid storm from The Japan Thyroid Association and Japan
Endocrine Society (First edition)
14. Staffurt J S, Gibberd J S, Tang FS: Arterial embolism in
thyrotoxicosis with atrial fibrillation. Br Med J 1977, 2:688-690
15. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin
concentrations as a risk factor for atrial fibrillation in older
persons. N Engl J Med. 1994 Nov 10;331(19):1249-52.
16.Bartalena L, Diagnosis and management of Graves disease: a global
overview. Nat Rev Endocrinol 2013; 9: 724–734.
17.Thurnheer R, Jenni R, Russi EW, et al. Hyperthyroidism and pulmonary
hypertension. J Intern Med 1997;242:185-8.
18.Eleftheraidis D, Fourlas E.
Eleftheriadis, N,
Hidden hyperthyroidism in a young male patient. Int J Cardiol 2003
Jun;89(2-3):313-4
19. Holmes S. J, Espiner E. A, Richards A M, et al. Renal, endocrine,
and hemodynamic effects of human brain natriuretic peptide in normal
man. J. Clin. Endocrinol. Metab. 1993, 76, 91–96.
20. Myers J D, Brannon E S, Holland B C. A correlative study of the
cardiac output and the hepatic circulation in hyperthyroidism. J Clin
Invest1950; 29(8): 1069–1077.
21. Pasyechko N V, Kuleshko I I, Kulchinska V M. et al. Ultrastructural
liver changes in the experimental thyrotoxicosis, Pol J Pathol 2017; 68
(2): 144-147
22 Alvarez A M, Mukherjee D, Liver Abnormalities in Cardiac Diseases and
Heart Failure. Int J Angiol 2011;20:135–142.